234 related articles for article (PubMed ID: 20070897)
1. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1.
Kovalenko PL; Zhang Z; Cui M; Clinton SK; Fleet JC
BMC Genomics; 2010 Jan; 11():26. PubMed ID: 20070897
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
3. microRNAs and DICER1 are regulated by 1,25-dihydroxyvitamin D in prostate stroma.
Dambal S; Giangreco AA; Acosta AM; Fairchild A; Richards Z; Deaton R; Wagner D; Vieth R; Gann PH; Kajdacsy-Balla A; Van der Kwast T; Nonn L
J Steroid Biochem Mol Biol; 2017 Mar; 167():192-202. PubMed ID: 28089917
[TBL] [Abstract][Full Text] [Related]
4. Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells.
Wang WL; Chatterjee N; Chittur SV; Welsh J; Tenniswood MP
Mol Cancer; 2011 May; 10():58. PubMed ID: 21592394
[TBL] [Abstract][Full Text] [Related]
5. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
6. Activation of rapid signaling pathways does not contribute to 1 alpha,25-dihydroxyvitamin D3-induced growth inhibition of mouse prostate epithelial progenitor cells.
Li J; Fleet JC; Teegarden D
J Cell Biochem; 2009 Aug; 107(5):1031-6. PubMed ID: 19492419
[TBL] [Abstract][Full Text] [Related]
7. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.
Rohan JN; Weigel NL
Endocrinology; 2009 May; 150(5):2046-54. PubMed ID: 19164469
[TBL] [Abstract][Full Text] [Related]
8. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
[TBL] [Abstract][Full Text] [Related]
9. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis.
Peehl DM; Shinghal R; Nonn L; Seto E; Krishnan AV; Brooks JD; Feldman D
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):131-41. PubMed ID: 15555907
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
11. Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells.
Bao BY; Ting HJ; Hsu JW; Lee YF
Int J Cancer; 2008 Jun; 122(12):2699-706. PubMed ID: 18348143
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression.
Krishnan AV; Peehl DM; Feldman D
J Cell Biochem; 2003 Feb; 88(2):363-71. PubMed ID: 12520538
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC
Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active RAS signaling reduces 1,25 dihydroxyvitamin D-mediated gene transcription in intestinal epithelial cells by reducing vitamin D receptor expression.
DeSmet ML; Fleet JC
J Steroid Biochem Mol Biol; 2017 Oct; 173():194-201. PubMed ID: 28104492
[TBL] [Abstract][Full Text] [Related]
15. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells.
Zhang Z; Kovalenko P; Cui M; Desmet M; Clinton SK; Fleet JC
J Cell Physiol; 2010 Aug; 224(2):433-42. PubMed ID: 20432439
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT
Fleet JC; Kovalenko PL; Li Y; Smolinski J; Spees C; Yu JG; Thomas-Ahner JM; Cui M; Neme A; Carlberg C; Clinton SK
Cancer Prev Res (Phila); 2019 Jun; 12(6):343-356. PubMed ID: 31028080
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.
Maund SL; Barclay WW; Hover LD; Axanova LS; Sui G; Hipp JD; Fleet JC; Thorburn A; Cramer SD
Cancer Res; 2011 Aug; 71(15):5276-86. PubMed ID: 21653679
[TBL] [Abstract][Full Text] [Related]
19. Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance.
Lai GR; Lee YF; Yan SJ; Ting HJ
Am J Physiol Cell Physiol; 2020 May; 318(5):C836-C847. PubMed ID: 32159363
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
